Biogen
BIIB
#1069
Rank
ยฃ14.55 B
Marketcap
ยฃ99.33
Share price
-0.57%
Change (1 day)
-41.87%
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

Biogen (BIIB) - P/B ratio

P/B ratio as of July 2025 : 1.15

According to Biogen's latest financial reports the company has a price-to-book ratio of 1.99527.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Biogen - P/B ratio (from 2004 to 2025)

P/B ratio by year

Year P/B ratio Change
2025-12-31N/A-100%
2024-12-311.32-47.94%
2023-12-312.53-14.94%
2022-12-312.98-7.38%
2021-12-313.22-8.8%
2020-12-313.53-9.01%
2019-12-313.88-14.9%
2018-12-314.55-14.85%
2017-12-315.355.12%
2016-12-315.09-28.78%
2015-12-317.14-2.98%
2014-12-317.36-3.93%
2013-12-317.6654.13%
2012-12-314.9719.55%
2011-12-314.1640.54%
2010-12-312.9626.03%
2009-12-312.35-0.14%
2008-12-312.35-22.67%
2007-12-313.0431.12%
2006-12-312.324.22%
2005-12-312.23-32.87%
2004-12-313.32
2003-12-31N/A
2002-12-31N/A

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
Amgen
AMGN
25.6 2,122.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
7.29 532.30%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
231 19,934.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
1.60 38.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
4.82 317.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-0.0044-100.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
1.49 29.13%๐Ÿ‡ซ๐Ÿ‡ท France
Bio-Rad Laboratories
BIO
1.03-11.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
6.62 474.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Qiagen
QGEN
3.07 165.81%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands